CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Covidfree@homeWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (1)


Name (Synonyms) Correlation
drug2932 olfactory device Wiki 1.00

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Covidfree@Home: At Home Monitoring Using Mobile Devices for Patients With Covid19

The vast majority of individuals with Covid19 have mild illness that can be managed in the outpatient setting. A small but significant number of these people will deteriorate and require hospitalization. Symptoms are a poor - and possibly late - indicator for deterioration. While people who have died, and/or been cared for in the ICU or hospital have been well characterized, there remains a dearth of information about the clinical course of people in the outpatient setting. Most notably, it is not known when to escalate to hospital care. The consequence of non-escalation when needed is significant patient morbidity and mortality, of escalation when not needed is unnecessarily overwhelmed hospitals. Technologies for clinical management and early diagnostics for severe Covid19 infection will address this challenge. The research goal of this study is to use real-time remote patient monitoring to detect which patients with Covid19 are at risk of deterioration to bring to hospital, while at the same ensuring the worried will receive reassurance so they stay at home. The clinical goal is to help clinicians provide excellent care using ubiquitous mobile phones.

NCT04453774 Coronavirus Device: Covidfree@home
MeSH:Coronavirus Infections

Primary Outcomes

Description: Number of participants with an unplanned emergency department visits leading to hospital admission

Measure: Number of participants with an unplanned hospital admissions

Time: 30 days

Description: Number of participants with planned hospital admissions that are found to be necessary

Measure: Number of participants with planned hospital admissions that are found to be necessary

Time: 30 days

Secondary Outcomes

Description: Number of participants with an emergency department visit not resulting in a hospital admission

Measure: Number of participants with an emergency department visits not resulting in hospital admission

Time: 30 days

Description: Number of planned hospital admissions which are found to be unnecessary

Measure: Number of planned hospital admissions which are found to be unnecessary

Time: 30 days


No related HPO nodes (Using clinical trials)